AMGEN 20090482- A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) In the treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma

A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) In the treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma

AMGEN 20090482
Hematology (Blood)
Saad Jamshed, MD
Enrolling
Denise Maracle, RN
(585) 747-4555
(585) 922-9146